[go: up one dir, main page]

DE60103978D1 - Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten - Google Patents

Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten

Info

Publication number
DE60103978D1
DE60103978D1 DE60103978T DE60103978T DE60103978D1 DE 60103978 D1 DE60103978 D1 DE 60103978D1 DE 60103978 T DE60103978 T DE 60103978T DE 60103978 T DE60103978 T DE 60103978T DE 60103978 D1 DE60103978 D1 DE 60103978D1
Authority
DE
Germany
Prior art keywords
virus
related diseases
combating cancer
product derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60103978T
Other languages
English (en)
Inventor
S Murthy
A Steenaart
A Johnson
C Shore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gemin X Pharmaceuticals Canada Inc
Original Assignee
Gemin X Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemin X Biotechnologies Inc filed Critical Gemin X Biotechnologies Inc
Application granted granted Critical
Publication of DE60103978D1 publication Critical patent/DE60103978D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60103978T 2000-01-26 2001-01-24 Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten Expired - Lifetime DE60103978D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/491,712 US6407244B1 (en) 2000-01-26 2000-01-26 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
PCT/CA2001/000085 WO2001055131A2 (en) 2000-01-26 2001-01-24 Prodigiosin-derivatives as neoplastic and anti-viral agents

Publications (1)

Publication Number Publication Date
DE60103978D1 true DE60103978D1 (de) 2004-07-29

Family

ID=23953337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103978T Expired - Lifetime DE60103978D1 (de) 2000-01-26 2001-01-24 Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten

Country Status (19)

Country Link
US (2) US6407244B1 (de)
EP (2) EP1431286A3 (de)
JP (1) JP2003523352A (de)
KR (1) KR20020072295A (de)
CN (1) CN1419553A (de)
AT (1) ATE269859T1 (de)
AU (1) AU780647B2 (de)
BR (1) BR0107912A (de)
CA (1) CA2398173A1 (de)
CZ (1) CZ20022604A3 (de)
DE (1) DE60103978D1 (de)
IL (1) IL150817A0 (de)
MX (1) MXPA02007271A (de)
NO (1) NO20023486L (de)
NZ (1) NZ520361A (de)
PL (1) PL356932A1 (de)
SK (1) SK10952002A3 (de)
WO (1) WO2001055131A2 (de)
ZA (1) ZA200205838B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014987A1 (en) * 2000-01-26 2004-01-22 Gemin X Biotechnologies Inc. Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
US7144912B2 (en) * 2001-07-18 2006-12-05 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
US20030119894A1 (en) * 2001-07-20 2003-06-26 Gemin X Biotechnologies Inc. Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells
JP2005531391A (ja) * 2002-06-27 2005-10-20 微創医療器械（上海）有限公司 薬剤放出ステント
PL1644363T3 (pl) * 2003-05-30 2012-07-31 Gemin X Pharmaceuticals Canada Inc Związki triheterocykliczne, kompozycje i metody leczenia raka
WO2006069441A1 (en) * 2004-12-28 2006-07-06 Gemin X Biotechnologies Inc. Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
US8247423B2 (en) * 2007-07-12 2012-08-21 Tragara Pharmaceuticals, Inc. Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
US20110301209A1 (en) * 2007-11-28 2011-12-08 Tragara Pharmaceuticals, Inc. Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
CN103145719B (zh) * 2013-02-27 2015-04-29 中国科学院化学研究所 灵菌红素衍生物的制备方法
US10322123B2 (en) 2014-09-29 2019-06-18 The Penn State Research Foundation Compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73 to restore the P53 pathway signaling
US10111554B2 (en) 2015-03-20 2018-10-30 Meltz, LLC Systems for and methods of controlled liquid food or beverage product creation
US10314320B2 (en) 2015-03-20 2019-06-11 Meltz, LLC Systems for controlled liquid food or beverage product creation
KR101785428B1 (ko) 2016-04-21 2017-10-16 (주) 마이크로프랜드 반도체소자 테스트소켓
WO2018200922A1 (en) 2017-04-27 2018-11-01 Meltz, LLC Method for centrifugal extraction and apparatus suitable for carrying out this method
CN109942559A (zh) * 2019-03-08 2019-06-28 上海大学 呋喃二联吡咯化合物及其制备方法
US11724849B2 (en) 2019-06-07 2023-08-15 Cometeer, Inc. Packaging and method for single serve beverage product

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266028A (en) * 1979-02-21 1981-05-05 Kirin Beer Kabushiki Kaisha Process for preparation of prodigiosin
JPS55162768A (en) * 1979-06-06 1980-12-18 Kirin Brewery Co Ltd Carcinostatic
JPS6134403A (ja) 1984-07-26 1986-02-18 Nec Corp 光干渉計
JPS61280429A (ja) 1985-06-06 1986-12-11 Chugai Pharmaceut Co Ltd 免疫抑制剤
JPH02250828A (ja) 1989-03-23 1990-10-08 Nippon Kayaku Co Ltd 新規免疫抑制剤
JPH0586374A (ja) 1991-09-26 1993-04-06 Teikoku Sekiyu Kk 炭水化物を可燃性のガスに分解する方法
GB9326284D0 (en) 1993-12-23 1994-02-23 Erba Carlo Spa Pyrrolydenemethyl-derivatives and process for their preparation
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
GB9603212D0 (en) 1996-02-15 1996-04-17 Pharmacia Spa Process for the preparation of 2,2'-bipyrrolyl-pyrromethane derivatives
GB9619706D0 (en) 1996-09-20 1996-11-06 Pharmacia Spa Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole comp und
JP3949198B2 (ja) 1996-10-23 2007-07-25 赤穂化成株式会社 Ｖ−ＡＴＰａｓｅ 脱共役 Ｈ＋ ポンプ阻害剤
JP3949196B2 (ja) 1996-10-23 2007-07-25 赤穂化成株式会社 免疫抑制剤
GB9705035D0 (en) 1997-03-11 1997-04-30 Pharmacia & Upjohn Spa Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
KR100252197B1 (ko) 1997-09-20 2000-04-15 박호군 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신
JPH11209283A (ja) 1997-10-01 1999-08-03 Ako Kasei Co Ltd 抗癌剤
GB9726130D0 (en) 1997-12-10 1998-02-11 Pharmacia & Upjohn Spa 2,2'-BI-1H-pyrrole derivatives useful in the treatment of leukemia brought on by HTLV-I
GB9802745D0 (en) 1998-02-09 1998-04-08 Pharmacia & Upjohn Spa Benzyloxy prodigiosine compounds
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases

Also Published As

Publication number Publication date
US20030009032A1 (en) 2003-01-09
NO20023486D0 (no) 2002-07-22
WO2001055131A3 (en) 2002-03-07
ATE269859T1 (de) 2004-07-15
EP1255753A2 (de) 2002-11-13
ZA200205838B (en) 2004-03-08
US6407244B1 (en) 2002-06-18
CZ20022604A3 (cs) 2003-01-15
AU2991201A (en) 2001-08-07
EP1255753B1 (de) 2004-06-23
EP1431286A2 (de) 2004-06-23
CN1419553A (zh) 2003-05-21
NO20023486L (no) 2002-09-04
MXPA02007271A (es) 2004-07-30
NZ520361A (en) 2004-02-27
KR20020072295A (ko) 2002-09-14
WO2001055131A2 (en) 2001-08-02
CA2398173A1 (en) 2001-08-02
BR0107912A (pt) 2002-12-10
EP1431286A3 (de) 2004-07-28
AU780647B2 (en) 2005-04-07
SK10952002A3 (sk) 2003-01-09
PL356932A1 (en) 2004-07-12
JP2003523352A (ja) 2003-08-05
IL150817A0 (en) 2003-02-12
US6602879B2 (en) 2003-08-05

Similar Documents

Publication Publication Date Title
DE60103978D1 (de) Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten
ATE361287T1 (de) Neue indol-2-on derivate
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
EA200500853A1 (ru) 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
NO20045656L (no) Oftalmologisk anvendelse av roflumilast for behandlingen av oyesykdommer
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
IS2718B (is) Taxól-eflandi efnasambönd
EA200401114A3 (ru) Замещённые гидроксиэтиламины
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
BRPI0409427A (pt) composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
EE200200143A (et) 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine
DK0911026T3 (da) Creatinderivater for astma
DK1255734T3 (da) Hidtil ukendte isatin-derivater
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
ATE301997T1 (de) Antivirale therapie
DE60104288D1 (de) Antivirale therapie
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
EA200601270A1 (ru) Новые индено[2,1-a]индены и изоиндоло[2,1-a]индолы
PT1263444E (pt) Aplicacao de derivados de xantina para a preparacao de um medicamento destinado a prevencao ou ao tratamento da osteoporose

Legal Events

Date Code Title Description
8332 No legal effect for de